IPA (ImmunoPrecise Antibodies) Accumulated other comprehensive income (loss) : $2.01 Mil (As of Oct. 2024)

View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. ImmunoPrecise Antibodies's Accumulated other comprehensive income (loss) for the quarter that ended in Oct. 2024 was $2.01 Mil.

ImmunoPrecise Antibodies's quarterly Accumulated other comprehensive income (loss) increased from Apr. 2024 ($1.48 Mil) to Jul. 2024 ($1.89 Mil) and increased from Jul. 2024 ($1.89 Mil) to Oct. 2024 ($2.01 Mil).

ImmunoPrecise Antibodies's annual Accumulated other comprehensive income (loss) increased from Apr. 2022 ($-1.96 Mil) to Apr. 2023 ($1.95 Mil) but then declined from Apr. 2023 ($1.95 Mil) to Apr. 2024 ($1.48 Mil).

ImmunoPrecise Antibodies Accumulated other comprehensive income (loss) Historical Data

The historical data trend for ImmunoPrecise Antibodies's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Accumulated other comprehensive income (loss) Chart

ImmunoPrecise Antibodies Annual Data

Trend

Dec14

Dec15

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-0.21

-0.55

-1.96

1.95

1.48

ImmunoPrecise Antibodies Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															1.41	1.15	1.48	1.89	2.01

ImmunoPrecise Antibodies Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

ImmunoPrecise Antibodies Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

TQB:Germany TQB:Germany

Address

3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8

Website

https://www.ipatherapeutics.com

ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.